Abstract
Sodium channel blocker insecticides (SCBIs) are a relatively new class of insecticides that are represented by two commercially registered compounds, indoxacarb and metaflumizone. SCBIs, like pyrethroids and DDT, target voltage-gated sodium channels (VGSCs) to intoxicate insects. In contrast to pyrethroids, however, SCBIs inhibit VGSCs at a distinct receptor site that overlaps those of therapeutic inhibitors of sodium channels, such as local anesthetics, anticonvulsants and antiarrhythmics. This review will recount the development of the SCBI insecticide class from its roots as chitin synthesis inhibitors, discuss the symptoms of poisoning and evidence supporting inhibition of VGSCs as their mechanism of action, describe the current model for SCBI-induced inhibition of VGSCs, present a model for the receptor for SCBIs on VGSCs, and highlight differences between data collected from mammalian and insect experimental models.
Keywords: Voltage-gated sodium channels, sodium channel blocker insecticides, metaflumizone, indoxacarb, statedependent channel block, insecticide receptors.
Current Medicinal Chemistry
Title:Molecular Mechanism of Action and Selectivity of Sodium Ch annel Blocker Insecticides
Volume: 24 Issue: 27
Author(s): Kristopher Silver*, Ke Dong and Boris S. Zhorov
Affiliation:
- Department of Entomology, 1603 Old Claflin Place, 123 Waters Hall, Kansas State University, Manhattan, KS 66506,United States
Keywords: Voltage-gated sodium channels, sodium channel blocker insecticides, metaflumizone, indoxacarb, statedependent channel block, insecticide receptors.
Abstract: Sodium channel blocker insecticides (SCBIs) are a relatively new class of insecticides that are represented by two commercially registered compounds, indoxacarb and metaflumizone. SCBIs, like pyrethroids and DDT, target voltage-gated sodium channels (VGSCs) to intoxicate insects. In contrast to pyrethroids, however, SCBIs inhibit VGSCs at a distinct receptor site that overlaps those of therapeutic inhibitors of sodium channels, such as local anesthetics, anticonvulsants and antiarrhythmics. This review will recount the development of the SCBI insecticide class from its roots as chitin synthesis inhibitors, discuss the symptoms of poisoning and evidence supporting inhibition of VGSCs as their mechanism of action, describe the current model for SCBI-induced inhibition of VGSCs, present a model for the receptor for SCBIs on VGSCs, and highlight differences between data collected from mammalian and insect experimental models.
Export Options
About this article
Cite this article as:
Silver Kristopher*, Dong Ke and Zhorov S. Boris, Molecular Mechanism of Action and Selectivity of Sodium Ch annel Blocker Insecticides, Current Medicinal Chemistry 2017; 24 (27) . https://dx.doi.org/10.2174/0929867323666161216143844
DOI https://dx.doi.org/10.2174/0929867323666161216143844 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function
Current Genomics Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity
Current Medicinal Chemistry Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches
Current Pediatric Reviews VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Machine Learning Approaches in Parkinson’s Disease
Current Medicinal Chemistry Neuroactive Molecules in the Brains of Nonhuman Primates and Their Therapeutic Application to Neurodegenerative Disorders
Central Nervous System Agents in Medicinal Chemistry The Association of Very High Hair Manganese Accumulation and High Oxidative Stress in Mongolian People
Current Aging Science Fragile X Mental Retardation Protein: Many Partners and Multiple Targets for a Promiscuous Function
Current Genomics Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research The Oxygen Therapy
Current Medicinal Chemistry Apolipoprotein E4 Serum Concentration for Increased Sensitivity and Specificity of Diagnosis of Drug Treated Alzheimer’s Disease Patients vs. Drug Treated Parkinson’s Disease Patients vs. Age-matched Normal Controls
Current Alzheimer Research Spinal Muscular Atrophy: Molecular Mechanisms
Current Molecular Medicine Adjunctive Depot Antipsychotic in Treatment-Resistant Schizophrenia
Current Psychopharmacology Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Neuroprotective Therapy for HIV Dementia
Current HIV Research Cell and Gene Therapies for Refractory Epilepsy
Current Neuropharmacology Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutic Strategies for Huntingtons Disease: From the Bench to the Clinic
Current Psychopharmacology